Anjum A, Yazid M D, Fauzi Daud M,et al.Spinal cord injury: pathophysiology, multimolecular interactions, and underlying recovery mechanisms[J]. Int J Mol Sci,2020,21(20):7533.
[3]
Li C,Wu Z,Zhou L,et al. Temporal and spatial cellular and molecular pathological alterations with single-cell resolution in the adult spinal cord after injury[J]. Signal Transduct Target Ther,2022,7(1):65.
[4]
Eli I, Lerner D P, Ghogawala Z. Acute traumatic spinal cord injury[J]. Neurol Clin,2021,39(2):471-488.
[5]
Fan B, Wei Z, Yao X, et al.Microenvironment imbalance of spinal cord injury[J]. Cell Transplant,2018,27(6):853-866.
Nagappan P G, Chen H, Wang D Y. Neuroregeneration and plasticity: a review of the physiological mechanisms for achieving functional recovery postinjury[J]. Mil Med Res,2020,7(1):30.
[8]
Baltrusch S. The role of neurotropic B vitamins in nerve regeneration[J]. Biomed Res Int,2021,2021:9968228.
[9]
Willand M P, Nguyen M A, Borschel G H, et al.Electrical stimulation to promote peripheral nerve regeneration[J]. Neurorehabil Neural Repair,2016,30(5):490.
[10]
Faroni A, Mobasseri S A, Kingham P J, et al.Peripheral nerve regeneration: experimental strategies and future perspectives[J]. Adv Drug Deliv Rev,2015,82-83:160.
Shanley K L, Hu C L, Bizzozero O A. Proteasome composition in cytokine-treated neurons and astrocytes is determined mainly by subunit displacement[J]. Neurochem Res,2020,45(4):860-871.
[20]
Dailey T, Tajiri N, Kaneko Y. Regeneration of neuronal cells following cerebral injury[J]. Front Neurol Neurosci, 2013,32:54-61.
[21]
Kichula E A, Proud C M, Farrar M A,et al. Expert recommendations and clinical considerations in the use of onasemnogene abeparvovec gene therapy for spinal muscular atrophy[J]. Muscle Nerve,2021,64(4):413-427.
[22]
Britten-Jones A C, Jin R, Gocuk S A,et al. The safety and efficacy of gene therapy treatment for monogenic retinal and optic nerve diseases: a systematic review[J]. Genet Med,2022,24(3):521-534.
Jiang L, Jones S, Jia X. Stem cell transplantation for peripheral nerve regeneration: current options and opportunities[J]. Int J Mol Sci,2017,18(1):94.
[25]
Assinck P, Duncan G J, Hilton B J,et al. Cell transplantation therapy for spinal cord injury[J]. Nat Neurosci,2017,20(5):637-647.
Curtis E, Martin J R, Gabel B,et al. A First-in-Human, phase I study of neural stem cell transplantation for chronic spinal cord injury[J]. Cell Stem Cell, 2018,22(6):941-950.
[28]
Huang L, Zhang L. Neural stem cell therapies and hypoxic-ischemic brain injury[J]. Prog Neurobiol,2019,173:1-17.
[29]
O’Brien A L, West J M, Saffari T M,et al. Promoting nerve regeneration: electrical stimulation, gene therapy, and beyond[J]. Physiology (Bethesda),2022,37(6):10.
[30]
Gordon T. Peripheral nerve regeneration and muscle reinnervation[J]. Int J Mol Sci, 2020,21(22):8652.
[31]
Chen Y C, Ma N X, Pei Z F,et al. A neuroD1 AAV-Based gene therapy for functional brain repair after ischemic injury through in vivo astrocyte-to-neuron conversion[J]. Mol Ther,2020,28(1):217-234.
[32]
Busuttil F, Rahim A A, Phillips J B. Combining gene and stem cell therapy for peripheral nerve tissue engineering[J]. Stem Cells Dev, 2017,26(4):231-238.
[33]
De Winter F, Hoyng S, Tannemaat M,et al. Gene therapy approaches to enhance regeneration of the injured peripheral nerve[J]. Eur J Pharmacol,2013,719(1-3):145-152.
[34]
Zhou Q, Zhang Y, Zou Y,et al. Human embryo gene editing: God's scalpel or Pandora’s box[J]. Brief Funct Genomics, 2020,19(3):154-163.
[35]
Sudhakar V, Richardson R M. Gene therapy for neurodegenerative diseases[J]. Neurotherapeutics, 2019,16(1):166-175.
Lee J H,Kim K H,Kwon O H,et al. Photodynamic ctivity of rotoporphyrin ix-immobilized cellulose monolith for nerve tissue regeneration[J]. Int J Mol Sci,2022,23(3):1035.
[38]
Jing X,Xu C,Su W,et al. Photosensitive and conductive hydrogel induced innerved bone regeneration for infected bone defect repair[J]. Adv Healthc Mater,2023,12(3):e2201349.
2023, Vol. 34 
